tiprankstipranks
Advertisement
Advertisement

CH:DOCM Stock Latest News

RatingsBuy Rating Backed by Strong 2026 Start, Balanced Segment Growth and Clear Path to Q4 Profit Break-Even
3d ago
PremiumCompany Announcements
DocMorris Q1 2026 Growth and Profitability Gains Reinforce Path to Break-Even
3d ago
PremiumCompany Announcements
DocMorris Board Urges Shareholders to Block ‘Creeping Takeover’ at May General Meeting
3d ago
DocMorris AG Charts Costly Yet Credible Turnaround
PremiumCompany Announcements
DocMorris AG Charts Costly Yet Credible Turnaround
23d ago
DocMorris price target lowered to CHF 4.45 from CHF 8.10 at Berenberg
PremiumThe Fly
DocMorris price target lowered to CHF 4.45 from CHF 8.10 at Berenberg
25d ago
DocMorris price target lowered to CHF 4.50 from CHF 7 at Deutsche Bank
PremiumThe FlyDocMorris price target lowered to CHF 4.50 from CHF 7 at Deutsche Bank
26d ago
DocMorris: Credible Turnaround and Improving EBITDA Outlook Support Buy Rating
Premium
Ratings
DocMorris: Credible Turnaround and Improving EBITDA Outlook Support Buy Rating
1M ago
DocMorris Hits 2025 Targets as It Accelerates AI-Driven Health Platform Shift
Premium
Company Announcements
DocMorris Hits 2025 Targets as It Accelerates AI-Driven Health Platform Shift
1M ago
DocMorris Taps Google AI to Power Next-Generation European Digital Health Platform
PremiumCompany Announcements
DocMorris Taps Google AI to Power Next-Generation European Digital Health Platform
1M ago
DocMorris Overhauls Board to Strengthen Digital Health and Governance Expertise
PremiumCompany Announcements
DocMorris Overhauls Board to Strengthen Digital Health and Governance Expertise
2M ago
DocMorris Triggers Early Redemption of 2026 Convertible Bond After Major Buyback
PremiumCompany Announcements
DocMorris Triggers Early Redemption of 2026 Convertible Bond After Major Buyback
3M ago
DocMorris further trims 2026 convertible bond, cutting outstanding amount below CHF 8 million
PremiumCompany Announcements
DocMorris further trims 2026 convertible bond, cutting outstanding amount below CHF 8 million
3M ago
DocMorris: Strengthening Non-Rx Growth and Balance Sheet Underpin Buy Rating Despite Near-Term Losses
PremiumRatingsDocMorris: Strengthening Non-Rx Growth and Balance Sheet Underpin Buy Rating Despite Near-Term Losses
3M ago
DocMorris Lifts 2025 Revenue 11% on Rx Surge and Digital Health Push
Premium
Company Announcements
DocMorris Lifts 2025 Revenue 11% on Rx Surge and Digital Health Push
3M ago
DocMorris Completes Convertible Bonds Repurchase Offer
Premium
Company Announcements
DocMorris Completes Convertible Bonds Repurchase Offer
5M ago
DocMorris Initiates Buyback Offer for 2026 Convertible Bonds
PremiumCompany Announcements
DocMorris Initiates Buyback Offer for 2026 Convertible Bonds
5M ago
DocMorris Completes CHF 49.6 Million Convertible Bond Issuance
PremiumCompany Announcements
DocMorris Completes CHF 49.6 Million Convertible Bond Issuance
6M ago
DocMorris Launches CHF 45 Million Convertible Bond for Strategic Repurchase
PremiumCompany Announcements
DocMorris Launches CHF 45 Million Convertible Bond for Strategic Repurchase
6M ago
Positive Growth Trends and Strategic Outlook Justify Buy Rating for DocMorris
PremiumRatings
Positive Growth Trends and Strategic Outlook Justify Buy Rating for DocMorris
6M ago
DocMorris Reports Strong Revenue Growth and Strategic AI Expansion
PremiumCompany AnnouncementsDocMorris Reports Strong Revenue Growth and Strategic AI Expansion
6M ago
DocMorris: Strategic Growth and Innovation Drive Buy Recommendation
Premium
Ratings
DocMorris: Strategic Growth and Innovation Drive Buy Recommendation
7M ago
Zur Rose Group AG: Earnings Call Highlights Growth and Innovation
Premium
Company Announcements
Zur Rose Group AG: Earnings Call Highlights Growth and Innovation
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >